Literature DB >> 16934068

Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis.

France Noizat-Pirenne1, Christophe Tournamille, Philippe Bierling, Françoise Roudot-Thoraval, Pierre-Yves Le Pennec, Philippe Rouger, Hélène Ansart-Pirenne.   

Abstract

BACKGROUND: It has long been known that relative immunogenicity is a characteristic of protein red blood cell (RBC) antigens, but the mechanisms remain unclear. The aim of this work was to elucidate the mechanisms underlying this relative immunogenicity. STUDY DESIGN AND METHODS: Two RBC antigens were used as a model--the highly immunogenic K antigen (KEL1) and the less immunogenic Fya antigen (FY1)--and analyzed the distribution of DRB1* molecules in two groups of Caucasian individuals producing anti-Fya (n = 29) or anti-K (n = 30) alloantibodies. These experimental results were compared to the results generated by TEPITOPE, a DRB1* peptide-binding motif prediction algorithm.
RESULTS: It was found that within the anti-Fya group, the DRB1*04 phenotypic frequency was 100 percent, indicating that the DRB1*04 molecule is the restriction molecule. In the anti-K group, numerous DRB1* molecules were identified, demonstrating a high degree of histocompatibility promiscuity, corresponding to the predominant molecules in the Caucasian population. These findings were confirmed by TEPITOPE.
CONCLUSION: These results strongly suggest that protein RBC intrinsic immunogenicity depends on the distribution of DRB1* restriction molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934068     DOI: 10.1111/j.1537-2995.2006.00900.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  29 in total

1.  Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Authors:  Nicole H Smith; Eldad A Hod; Steven L Spitalnik; James C Zimring; Jeanne E Hendrickson
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Immune Regulation of sickle Cell Alloimmunization.

Authors:  Karina Yazdanbakhsh; Beth H Shaz; Christopher D Hillyer
Journal:  ISBT Sci Ser       Date:  2016-11-15

3.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

4.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 5.  Cellular immune responses in red blood cell alloimmunization.

Authors:  James C Zimring; Krystalyn E Hudson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Heather Gordish-Dressman; Ross Fasano; Michael Riggs; Catherine Fortier; Andrew D Campbell; Dominique Charron; Victor R Gordeuk; Naomi L C Luban; Stanislav Vukmanovic; Ryad Tamouza
Journal:  Hum Immunol       Date:  2015-10-22       Impact factor: 2.850

7.  Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.

Authors:  Weili Bao; Hui Zhong; Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

8.  Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Steven L Spitalnik; Christopher D Hillyer; James C Zimring
Journal:  Transfusion       Date:  2009-11-09       Impact factor: 3.157

9.  Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope.

Authors:  Krystalyn E Hudson; Eugene Lin; Jeanne E Hendrickson; Aron E Lukacher; James C Zimring
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

10.  Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.

Authors:  Gláucia A S Guelsin; Camila Rodrigues; Jeane E L Visentainer; Paula De Melo Campos; Fabíola Traina; Simone C O Gilli; Sara T O Saad; Lilian Castilho
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.